Predictors of peri-opertative morbidity and liver dysfunction after hepatic resection in patients with chronic liver disease

HPB

Volumn 13, Issue 8, 2011, Pages 559-565

  Greco, Elisa ^a   Nanji, Sulaiman ^b   Bromberg, Irvin L ^c   Shah, Shimul ^d   Wei, Alice C ^a   Moulton, Carol Anne ^a   Greig, Paul D ^a   Gallinger, Steven ^a   Cleary, Sean P ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d University of Massechusetts Medical School   (Canada)

Author keywords

cirrhosis < liver; hepatocellular carcinoma < liver; resection < liver

Indexed keywords

INDOCYANINE GREEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DISEASE MODEL; END STAGE LIVER DISEASE; FEMALE; HEMIHEPATECTOMY; HUMAN; INTERNATIONAL NORMALIZED RATIO; LABORATORY TEST; LENGTH OF STAY; LIVER CELL CARCINOMA; LIVER DYSFUNCTION; LIVER FUNCTION TEST; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PERIOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; RETROSPECTIVE STUDY; SURGICAL MORTALITY; TREATMENT OUTCOME;

EID: 79960556686     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2011.00329.x     Document Type: Article

References (17)

1. Bruix J, Sherman M, Llovet JM, Beaugard M, Lencioni R, Burroughs A, et al,. (2001) Clinical management of hepatocellular carcinoma. Conclusion of the Barcelona-2000 EASL Conference. J Hepatol 35: 421-430. (Pubitemid 32844200)
2. Shah SA, Cleary SP, Wei AC, Yang I, Taylor BR, Hemming AW, et al,. (2007) Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, outcomes. Surgery 141: 330-339. (Pubitemid 46371307)
3. Llovet J, Bruix J,. (2002) Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 35: 519-524. (Pubitemid 34183954)
4. Teh SH, Christein J, Donohue J, Que F, Kendrick M, Farnell M, et al,. (2005) Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: model of end-stage liver disease (MELD) score predicts preoperative mortality. J Gastrointest Surg 9: 1207-1215. (Pubitemid 41751112)
5. Befeler AS, Palmer DE, Hoffman M, Longo W, Solomon H, Di Bisceglie AM,. (2005) The safety of intra-abdominal surgery in patients with cirrhosis. Arch Surg 140: 650-654.
6. Ohwada S, Kawate S, Hamada K, Yamada T, Sunose Y, Tsutsumi H, et al,. (2006) Perioperative real-time monitoring of indocyanine green clearance by pulse spectrophotometry predicts remnant liver fuctional reserve in resection of hepatocellular carcinoma. Br J Surg 93: 229-246.
7. Faybik P, Hetz H,. (2006) Plasma disappearance rate of indocyanine green in liver dysfunction. Transplant Proc 38: 801-802.
8. Lam CM, Fan ST, Lo CM, Wong J,. (1999) Major hepatectomy for hepatocellular carcinoma in patients with an unsatisfactory indocyanine green clearance test. Br J Surg 86: 1012-1017. (Pubitemid 29387065)
9. Lau H, Man K, Fan ST, Yu WC, Lo CM, Wong J,. (1997) Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg 84: 1255-1259. (Pubitemid 27400276)
10. Dixon E, Sahajpal A, Vollmer CM, Cattral M, Greig PD,. (2004) Multipurpose extended subcostal incision for hepatobiliary surgery. Am J Surg 187: 128-130. (Pubitemid 38045519)
11. Miyagawa S, Makuuchi M, Kawasaki S, Kakazu T,. (1995) Criteria for safe hepatic resection. Am J Surg 169: 589-594.
12. Tsui Y, Scherer MN, Schnitzbauer AA, Schlitt HJ, Obed A,. (2009) Adult living donor liver transplantations: body mass index and MELD score of recipients are independent risk factors for hospital mortality. Langenbecks Arch Surg 394: 235-241.
13. Cucchetti A, Ercolani G, Cescon M, Tavaioli M, Zanello M, Del Gaudio M, et al,. (2006) Recovery from liver failure after hepatectomy for hepatocellular carcinoma in cirrhosis: meaning of the model for end-stage liver disease. J Am Coll Surg 203: 670-676. (Pubitemid 44648768)
14. Schoeder RA, Marroquin CE, Bute BP, Khuri S, Henderson WG, Kuo PC,. (2006) Predictive indices of morbidity and mortality after liver resection. Ann Surg 243: 373-379. (Pubitemid 43327770)
15. Hemming AW, Scudamore CH, Shackleton CR, Pudek M, Erb SR,. (1992) Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients. Am J Surg 163: 515-518.
16. Sheng QS, Lang R, He Q, Yang YJ, Zhao DF, Cheng DZ,. (2009) Indocyanine green clearance test and model for end-stage liver disease score of patients with liver cirrhosis. Hepatobiliary Pancreat Dis Int 8: 46-49.
17. Cucchetti A, Ercolani G, Vivarelli M, Cescon M, Ravaioli M, La Barba G, et al,. (2006) Impact of Model for End-Stage Liver Disease score prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. Liver Transpl 12: 966-971. (Pubitemid 43960373)